Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection

Journal of Clinical Virology

Volumn 49, Issue 3, 2010, Pages 163-168

  Enders, Martin ^a   Klingel, Karin ^b   Weidner, Andrea ^a   Baisch, Carola ^a   Kandolf, Reinhard ^b   Schalasta, Gunnar ^a   Enders, Gisela ^a  

^a Infectious Diseases and Epidemiology eV   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Erythrovirus; Fetal death; Hydrops; Parvovirus B19; Pregnancy; Stillbirth

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; FETUS DEATH; FETUS HYDROPS; GESTATION PERIOD; HISTOPATHOLOGY; HUMAN; HUMAN PARVOVIRUS B19; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIVE BIRTH; MAJOR CLINICAL STUDY; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; ANTIBODIES, VIRAL; COHORT STUDIES; DNA, VIRAL; FEMALE; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; NUCLEIC ACID HYBRIDIZATION; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK ASSESSMENT;

EID: 77957688451     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.07.014     Document Type: Article

References (35)

1. Cohen B.J., Kumar S. Parvovirus B19 infection in pregnancy. Fetal Matern Med Rev 2005, 16:123-150.
2. Heinonen S., Ryynänen M., Kirkinen P. Etiology and outcome of second trimester non-immunologic fetal hydrops. Acta Obstet Gynecol Scand 2000, 79:15-18.
3. Hernandez-Andrade E., Scheier M., Dezerega V., Carmo A., Nicolaides K.H. Fetal middle cerebral artery peak systolic velocity in the investigation of non-immune hydrops. Ultrasound Obstet Gynecol 2004, 23:442-445.
4. Guidozzi F., Ballot D., Rothberg A.D. Human B19 parvovirus infection in an obstetric population. A prospective study determining fetal outcome. J Reprod Med 1994, 39:36-38.
5. Gratacós E., Torres P.J., Vidal J., Antolin E., Costa J., Jiménez de Anta M.T., et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995, 171:1360-1363.
6. Harger J.H., Adler S.P., Koch W.C., Harger G.F. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 1998, 91:413-420.
7. Koch W.C., Harger J.H., Barnstein B., Adler S.P. Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr Infect Dis J 1998, 17:489-494.
8. Miller E., Fairley C.K., Cohen B.J., Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998, 105:174-178.
9. Enders M., Weidner A., Zoellner I., Searle K., Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004, 24:513-518.
10. Chisaka H., Ito K., Niikura H., Sugawara J., Takano T., Murakami T., et al. Clinical manifestations and outcomes of parvovirus B19 infection during pregnancy in Japan. Tohoku J Exp Med 2006, 209:277-283.
11. Schwarz T.F., Nerlich A., Hottenträger B., Jäger G., Wiest I., Kantimm S., et al. Parvovirus B19 infection of the fetus. Histology and in situ hybridization. Am J Clin Pathol 1991, 96:121-126.
12. Wright C., Hinchliffe S.A., Taylor C. Fetal pathology in intrauterine death due to parvovirus B19 infection. Br J Obstet Gynaecol 1996, 103:133-136.
13. Tolfvenstam T., Papadogiannakis N., Norbeck O., Petersson K., Broliden K. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 2001, 357:1494-1497.
14. Norbeck O., Papadogiannakis N., Petersson K., Hirbod T., Broliden K., Tolfvenstam T. Revised clinical presentation of parvovirus B19-associated intrauterine fetal death. Clin Infect Dis 2002, 35:1032-1038.
15. Riipinen A., Väisänen E., Nuutila M., Sallmen M., Karikoski R., Lindbohm M.L., et al. Parvovirus b19 infection in fetal deaths. Clin Infect Dis 2008, 47:1519-1525.
16. Enders M., Weidner A., Enders G. Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiol Infect 2007, 135:563-569.
17. Erdman D.D., Usher M.J., Tsou C., Caul E.O., Gary G.W., Kajigaya S., et al. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol 1991, 35:110-115.
18. Manaresi E., Zuffi E., Gallinella G., Gentilomi G., Zerbini M., Musiani M. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins. J Med Virol 2001, 64:67-73.
19. Enders M., Schalasta G., Baisch C., Weidner A., Pukkila L., Kaikkonen L., et al. Human parvovirus B19 infection during pregnancy-value of modern molecular and serological diagnostics. J Clin Virol 2006, 35:400-406.
20. Enders M., Helbig S., Hunjet A., Pfister H., Reichhuber C., Motz M. Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection. J Virol Methods 2007, 146:409-413.
21. World Health Organization (WHO) International statistical classification of diseases and related health problems tenth revision (ICD-10) 1992, vol. 1. World Health Organization (WHO), Geneva, Switzerland, p. 1235-1236.
22. Doyle S., Kerr S., O'Keeffe G., O'Carroll D., Daly P., Kilty C. Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis. J Virol Methods 2000, 90:143-152.
23. Searle K., Guilliard C., Wallat S., Schalasta G., Enders G. Acute parvovirus B19 infection in pregnant women--an analysis of serial samples by serological and semi-quantitative PCR techniques. Infection 1998, 26:139-143.
24. Schalasta G., Schmid M., Lachmund T., Enders G. LightCycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates. J Med Virol 2004, 73:54-59.
25. Klingel K., Hohenadl C., Canu A., Albrecht M., Seemann M., Mall G., et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 1992, 89:314-318.
26. Bültmann B.D., Klingel K., Sotlar K., Bock C.T., Baba H.A., Sauter M., et al. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 2003, 34:92-95.
27. Cohen B.J., Bates C.M. Evaluation of 4 commercial test kits for parvovirus B19-specific IgM. J Virol Methods 1995, 55:11-25.
28. de Ory F., Guisasola M.E., Tellez A., Domingo C.J. Comparative evaluation of commercial methods for the detection of parvovirus B19-specific immunoglobulin M. Serodiagn Immunother Infect Dis 1996, 8:117-120.
29. Beigi R.H., Wiesenfeld H.C., Landers D.V., Simhan H.N. High rate of severe fetal outcomes associated with maternal parvovirus b19 infection in pregnancy. Infect Dis Obstet Gynecol 2008, 2008:524601.
30. Simms R.A., Liebling R.E., Patel R.R., Denbow M.L., Abdel-Fattah S.A., Soothill P.W., et al. Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit. Fetal Diagn Ther 2009, 25:373-378.
31. Yaegashi N., Niinuma T., Chisaka H., Uehara S., Okamura K., Shinkawa O., et al. Serologic study of human parvovirus B19 infection in pregnancy in Japan. J Infect 1999, 38:30-35.
32. Fairley C.K., Smoleniec J.S., Caul O.E., Miller E. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995, 346:1335-1337.
33. Rodis J.F., Borgida A.F., Wilson M., Egan J.F., Leo M.V., Odibo A.O., et al. Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians. Am J Obstet Gynecol 1998, 179:985-988.
34. von Kaisenberg C.S., Jonat W. Fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 2001, 18:280-288.
35. Sarfraz A.A., Samuelsen S.O., Bruu A.L., Jenum P.A., Eskild A. Maternal human parvovirus B19 infection and the risk of fetal death and low birthweight: a case-control study within 35 940 pregnant women. BJOG 2009, 116:1492-1498.